GOLD COPD DOCUMENT 2023: a Brief Update for Practicing Cardiologists

Overview

Journal Clin Res Cardiol

Specialty Cardiology & Vascular Diseases

Date 2023 May 26

PMID 37233751

Authors

Alvar Agusti

Michael Bohm

Bartolome Celli

Gerard J Criner

Ana Garcia-Alvarez

Fernando Martinez

Don D Sin

Claus F Vogelmeier

Affiliations

Soon will be listed here.

Abstract

Many patients seen by cardiologists suffer chronic obstructive pulmonary disease (COPD) in addition to their primary cardiovascular problem. Yet, quite often COPD has not been diagnosed and, consequently, patients have not been treated of their pulmonary disease. Recognizing and treating COPD in patients with CVDs is important because optimal treatment of the COPD carries important benefits on cardiovascular outcomes. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) publishes an annual report that serves as a clinical guideline for the diagnosis and management of COPD around the world and has very recently released the 2023 annual report. Here, we provide a summary of the GOLD 2023 recommendations that highlights those aspects of more interest for practicing cardiologists dealing with patients with CVD who may suffer COPD.

Citing Articles

The impact of smoking on respiratory rehabilitation efficacy and correlation analysis in patients with chronic obstructive pulmonary disease: a retrospective study.

Li M, Gao W J Thorac Dis. 2025; 17(1):254-264.

PMID: 39975758 PMC: 11833573. DOI: 10.21037/jtd-24-1267.

Bronchiectasis-COPD Overlap Syndrome: A Comprehensive Review of its Pathophysiology and Potential Cardiovascular Implications.

Alam M, Mangapuram P, Fredrick F, Singh B, Singla A, Kumar A Ther Adv Pulm Crit Care Med. 2024; 19:29768675241300808.

PMID: 39655338 PMC: 11626662. DOI: 10.1177/29768675241300808.

Lipomatous hypertrophy of the interatrial septum: a distinct adipose tissue type in COPD?.

Lacaita P, Kindl B, Plank F, Beyer C, Bilgeri V, Barbieri F ERJ Open Res. 2024; 10(5).

PMID: 39319042 PMC: 11417605. DOI: 10.1183/23120541.00295-2024.

A Multi-Specialty Delphi Consensus on Assessing and Managing Cardiopulmonary Risk in Patients with COPD.

Bhutani M, Bourbeau J, Goodman S, Hawkins N, Kaplan A, Lin P Int J Chron Obstruct Pulmon Dis. 2024; 19:2051-2062.

PMID: 39318837 PMC: 11420896. DOI: 10.2147/COPD.S471952.

A Research Agenda to Improve Outcomes in Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Disease: An Official American Thoracic Society Research Statement.

Myers L, Quint J, Hawkins N, Putcha N, Hamilton A, Lindenauer P Am J Respir Crit Care Med. 2024; 210(6):715-729.

PMID: 39133888 PMC: 11418885. DOI: 10.1164/rccm.202407-1320ST.

References

Soriano J, Rigo F, Guerrero D, Yanez A, Forteza J, Frontera G . High prevalence of undiagnosed airflow limitation in patients with cardiovascular disease. Chest. 2009; 137(2):333-40. DOI: 10.1378/chest.09-1264. View

Stolz D, Mkorombindo T, Schumann D, Agusti A, Ash S, Bafadhel M . Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission. Lancet. 2022; 400(10356):921-972. PMC: 11260396. DOI: 10.1016/S0140-6736(22)01273-9. View

Celli B, Fabbri L, Criner G, Martinez F, Mannino D, Vogelmeier C . Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision. Am J Respir Crit Care Med. 2022; 206(11):1317-1325. PMC: 9746870. DOI: 10.1164/rccm.202204-0671PP. View

Celli B, Fabbri L, Aaron S, Agusti A, Brook R, Criner G . An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal. Am J Respir Crit Care Med. 2021; 204(11):1251-1258. DOI: 10.1164/rccm.202108-1819PP. View

Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E . Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health. 2016; 5(2):020415. PMC: 4693508. DOI: 10.7189/jogh.05.020415. View

Lopez A, Shibuya K, Rao C, Mathers C, Hansell A, Held L . Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006; 27(2):397-412. DOI: 10.1183/09031936.06.00025805. View

Landis S, Muellerova H, Mannino D, Menezes A, Han M, van der Molen T . Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012-2013. Int J Chron Obstruct Pulmon Dis. 2014; 9:597-611. PMC: 4057333. DOI: 10.2147/COPD.S61854. View

Fletcher C, Peto R . The natural history of chronic airflow obstruction. Br Med J. 1977; 1(6077):1645-8. PMC: 1607732. DOI: 10.1136/bmj.1.6077.1645. View

Salvi S, Barnes P . Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009; 374(9691):733-43. DOI: 10.1016/S0140-6736(09)61303-9. View

10.

Blanco I, Diego I, Bueno P, Perez-Holanda S, Casas-Maldonado F, Miravitlles M . Prevalence of α-antitrypsin PiZZ genotypes in patients with COPD in Europe: a systematic review. Eur Respir Rev. 2020; 29(157). PMC: 9489008. DOI: 10.1183/16000617.0014-2020. View

11.

Agusti A, Hogg J . Update on the Pathogenesis of Chronic Obstructive Pulmonary Disease. N Engl J Med. 2019; 381(13):1248-1256. DOI: 10.1056/NEJMra1900475. View

12.

Agusti A, Noell G, Brugada J, Faner R . Lung function in early adulthood and health in later life: a transgenerational cohort analysis. Lancet Respir Med. 2017; 5(12):935-945. DOI: 10.1016/S2213-2600(17)30434-4. View

13.

Andrea R, Lopez-Giraldo A, Falces C, Sobradillo P, Sanchis L, Gistau C . Lung function abnormalities are highly frequent in patients with heart failure and preserved ejection fraction. Heart Lung Circ. 2013; 23(3):273-9. DOI: 10.1016/j.hlc.2013.08.003. View

14.

Andrea R, Lopez-Giraldo A, Falces C, Lopez T, Sanchis L, Gistau C . Pulmonary function predicts mortality and hospitalizations in outpatients with heart failure and preserved ejection fraction. Respir Med. 2018; 134:124-129. DOI: 10.1016/j.rmed.2017.12.004. View

15.

Celli B, Wedzicha J . Update on Clinical Aspects of Chronic Obstructive Pulmonary Disease. N Engl J Med. 2019; 381(13):1257-1266. DOI: 10.1056/NEJMra1900500. View

16.

Shaw L, Giambrone A, Blaha M, Knapper J, Berman D, Bellam N . Long-Term Prognosis After Coronary Artery Calcification Testing in Asymptomatic Patients: A Cohort Study. Ann Intern Med. 2015; 163(1):14-21. DOI: 10.7326/M14-0612. View

17.

Casanova C, Gonzalez-Davila E, Martinez-Gonzalez C, Cosio B, Fuster A, Feu N . Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex. Chest. 2021; 160(2):481-490. DOI: 10.1016/j.chest.2021.03.069. View

18.

Okuyemi K, Nollen N, Ahluwalia J . Interventions to facilitate smoking cessation. Am Fam Physician. 2006; 74(2):262-71. View

19.

Lee P, Fariss M . A systematic review of possible serious adverse health effects of nicotine replacement therapy. Arch Toxicol. 2016; 91(4):1565-1594. PMC: 5364244. DOI: 10.1007/s00204-016-1856-y. View

20.

Mills E, Thorlund K, Eapen S, Wu P, Prochaska J . Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis. Circulation. 2013; 129(1):28-41. PMC: 4258065. DOI: 10.1161/CIRCULATIONAHA.113.003961. View